Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT02548962 · TERMINATED
Trial details
- NCT number
- NCT02548962
- Sponsor
- Pharmacyclics LLC.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-06-13
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.